Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Shares Buyback Ratio % : 0.47 (As of May. 21, 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Zhejiang Jiuzhou Pharmaceutical Co's current shares buyback ratio was 0.47%.

Zhejiang Jiuzhou Pharmaceutical Co Shares Buyback Ratio % Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Shares Buyback Ratio % Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

0.05

-3.40

-0.20

-7.82

0.47

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Shares Buyback Ratio %	Get a 7-Day Free Trial															0.01	-	0.15	0.32	-

Zhejiang Jiuzhou Pharmaceutical Co Shares Buyback Ratio % Calculation

Zhejiang Jiuzhou Pharmaceutical Co's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(899.486	-	895.236)	/	899.486
	=	0.47%

Zhejiang Jiuzhou Pharmaceutical Co's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2024 )	-	Shares Outstanding (EOP) (A: Mar. 2025 ))	/	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	(895.236	-	895.236)	/	895.236
	=	0.00%

Zhejiang Jiuzhou Pharmaceutical Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jiuzhou Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Shares Buyback Ratio %

Traded in Other Exchanges

N/A

Address

No. 99 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000

Website

https://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Executives

Sha Yu Jie	Directors, senior managers
Mei Yi Jiang	Director
Li Yuan Qiang	senior management
Yang Nong Gang	senior management
	Directors, senior managers
Huang Min Xia	senior management
Wang Bin	Directors, senior managers
Dai Yun You	senior management
Jiang Zu Lin	Directors, senior managers
Guo Zhen Rong	senior management
Chen Zhi Hong	Directors, senior managers
Xu Jia Jun	Supervisors
Hua Li Rong	Director
Lin Hui Lu	senior management
Zhu Guo Liang	Supervisors

Zhejiang Jiuzhou Pharmaceutical Co Headlines

No Headlines